The burden posed by the Covid-19 pandemic on healthcare systems requires strategies to identify high-risk people in order to better allocate the available health resources and plan targeted care pathways [1]. Despite the growing evidence on the field, the heterogeneity of Covid-19 both in terms of clinical presentation has not yet made possible to disentangle the complexity of such disease [2–4].
